EXTRAGONADAL GERM CELL TUMOURS - Alberta Health Services

CLINICAL PRACTICE GUIDELINE GU-007
Version 1
6. Mizushima Y. Extragonadal germ cell tumors. Intern Med 2004 Dec;43(12):1099-1100.
7. Kesler KA, Einhorn LH. Multimodality treatment of germ cell tumors of the mediastinum. Thorac Surg Clin 2009
Feb;19(1):63-69.
8. Bokemeyer C, Hartmann JT, Fossa SD, Droz JP, Schmol HJ, Horwich A, et al. Extragonadal germ cell tumors:
relation to testicular neoplasia and management options. APMIS 2003 Jan;111(1):49-59; discussion 59-63.
9. British Columbia Cancer Agency. Testis. Cancer Management Guidelines- Genitourinary June 2005.
10. Bosl GJ, Ilson DH, Rodriguez E, Motzer RJ, Reuter VE, Chaganti RS. Clinical relevance of the i(12p) marker
chromosome in germ cell tumors. J Natl Cancer Inst 1994 Mar 2;86(5):349-355.
11. National Comprehensive Cancer Network. Testicular Cancer. Clinical Practice Guidelines in Oncology 2012;
v1.2012.
12. Albany C, Einhorn LH. Extragonadal germ cell tumors: clinical presentation and management. Curr Opin Oncol
2013, 25:261–265.
13. Motzer RJ, Nichols CJ, Margolin KA, Bacik J, Richardson PG, Vogelzang NJ, et al. Phase III randomized trial of
conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stemcell
rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors. J Clin Oncol 2007
Jan 20;25(3):247-256.
14. Nichols CR, Catalano PJ, Crawford ED, Vogelzang NJ, Einhorn LH, Loehrer PJ. Randomized comparison of
cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell
tumors: an Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group
B Study. J Clin Oncol 1998 Apr;16(4):1287-1293.
15. Hinton S, Catalano PJ, Einhorn LH, Nichols CR, David Crawford E, Vogelzang N, et al. Cisplatin, etoposide and
either bleomycin or ifosfamide in the treatment of disseminated germ cell tumors: final analysis of an intergroup
trial. Cancer 2003 Apr 15;97(8):1869-1875.
16. Hartmann JT, Einhorn L, Nichols CR, Droz JP, Horwich A, Gerl A, et al. Second-line chemotherapy in patients
with relapsed extragonadal nonseminomatous germ cell tumors: results of an international multicenter analysis. J
Clin Oncol 2001 Mar 15;19(6):1641-1648.
17. Pico JL, Rosti G, Kramar A, Wandt H, Koza V, Salvioni R, et al. A randomised trial of high-dose chemotherapy in
the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours. Ann
Oncol 2005 Jul;16(7):1152-1159.
18. Feldman DR, Sheinfeld J, Bajorin DF, Fischer P, Turkula S, Ishill N, et al. TI-CE high-dose chemotherapy for
patients with previously treated germ cell tumors: results and prognostic factor analysis. J Clin Oncol 2010 Apr
1;28(10):1706-1713.
19. Lorch A, Rick O, Wundisch T, Hartmann JT, Bokemeyer C, Beyer J. High dose chemotherapy as salvage
treatment for unresectable late relapse germ cell tumors. J Urol 2010 Jul;184(1):168-173.
20. Hidalgo M, Paz-Ares L, Rivera F, Lianes P, Huidobro G, Ruiz A, et al. Mediastinal non-seminomatous germ cell
tumours (MNSGCT) treated with cisplatin-based combination chemotherapy. Ann Oncol 1997 Jun;8(6):555-559.
21. Gerl A, Clemm C, Lamerz R, Wilmanns W. Cisplatin-based chemotherapy of primary extragonadal germ cell
tumors. A single institution experience. Cancer 1996 Feb 1;77(3):526-532.
22. Goss PE, Schwertfeger L, Blackstein ME, Iscoe NA, Ginsberg RJ, Simpson WJ, et al. Extragonadal germ cell
tumors. A 14-year Toronto experience. Cancer 1994 Apr 1;73(7):1971-1979.
23. Kesler KA, Rieger KM, Hammoud ZT, Kruter LE, Perkins SM, Turrentine MW, et al. A 25-year single institution
experience with surgery for primary mediastinal nonseminomatous germ cell tumors. Ann Thorac Surg 2008
Feb;85(2):371-378.
24. Ganjoo KN, Rieger KM, Kesler KA, Sharma M, Heilman DK, Einhorn LH. Results of modern therapy for patients
with mediastinal nonseminomatous germ cell tumors. Cancer 2000 Mar 1;88(5):1051-1056.
Page 8 of 8